HCA
ABBV icon

Harbor Capital Advisors’s AbbVie ABBV Stock Holding History

Harbor Capital Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.23M Buy
20,794
+136
+0.7% +$29.3K 0.36% 56
2026
Q1 		$4.49M Sell
20,658
-4,779
-19% -$1.06M 0.36% 48
2025
Q4 		$5.81M Sell
25,437
-37
-0.1% -$8.43K 0.45% 34
2025
Q3 		$5.9M Buy
25,474
+682
+3% +$139K 0.46% 33
2025
Q2 		$4.6M Sell
24,792
-142
-0.6% -$26.4K 0.19% 178
2025
Q1 		$5.22M Buy
+24,934
New +$4.85M 0.24% 149

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Harbor Capital Advisors's ABBV Position: Q2 2026 in Review

Harbor Capital Advisors increased its AbbVie (ABBV) stake by 0.66% in Q2 2026, buying an estimated $29.3K and bringing the position to 20,794 shares worth $5.23M. The position accounts for 0.36% of the portfolio, ranked #56.

Harbor Capital Advisors first reported a position in ABBV in Q1 2025 and has held it in 6 quarters since. The position peaked at $5.9M in Q3 2025. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Harbor Capital Advisors held 20,794 shares of AbbVie worth $5.23M as of Q2 2026.
  • Harbor Capital Advisors bought 136 AbbVie shares in Q2 2026, an estimated $29.3K.
  • AbbVie made up 0.36% of Harbor Capital Advisors's portfolio in Q2 2026, its #56 holding.
  • Harbor Capital Advisors first reported a position in AbbVie in Q1 2025 and has held it in 6 quarters since.
  • Harbor Capital Advisors's AbbVie position peaked at $5.9M in Q3 2025.
  • 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Harbor Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.